Efficacy and safety of disitamab vedotin combination therapy in HER2-positive advanced gynecological cancers: A multicenter retrospective analysis.
Authors: Jing Liu, Lele Chang, Xinyu Zhang, Qin Xu
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e17534
Source:
Full article
Abstract
e17534